PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
17.83%
Net income growth under 50% of ORCL's 40.55%. Michael Burry would suspect deeper structural issues in generating bottom-line growth.
-1.12%
Negative yoy D&A while ORCL is 9.15%. Joel Greenblatt would note a short-term EPS advantage unless competitor invests for future advantage.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-167.19%
Both reduce yoy usage, with ORCL at -222.43%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-167.19%
Both reduce yoy usage, with ORCL at -222.43%. Martin Whitman would suspect an industry or cyclical factor pulling back on these items.
392.94%
Well above ORCL's 85.04%. Michael Burry would worry about large intangible write-downs or revaluation gains overshadowing real performance.
-16.76%
Both yoy CFO lines are negative, with ORCL at -95.18%. Martin Whitman would suspect cyclical or cost factors harming the entire niche’s cash generation.
-27.36%
Negative yoy CapEx while ORCL is 4.20%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
No Data
No Data available this quarter, please select a different quarter.
34.64%
Less growth in investment purchases vs. ORCL's 511.43%, preserving near-term liquidity. David Dodd would confirm no strategic investment opportunities are lost.
No Data
No Data available this quarter, please select a different quarter.
-1759.09%
We reduce yoy other investing while ORCL is 3.96%. Joel Greenblatt sees a near-term cash advantage unless competitor’s intangible or side bets produce strong returns.
-9.40%
We reduce yoy invests while ORCL stands at 116.72%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
No Data
No Data available this quarter, please select a different quarter.
-20.89%
Negative yoy issuance while ORCL is 490.32%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
46.83%
We have some buyback growth while ORCL is negative at -491.88%. John Neff sees a short-term advantage in boosting EPS unless expansions hamper competitor.